APA

Bisschop C., Wind T. T., Blank C. U., Koornstra R. H. T., Kapiteijn E., Van den Eertwegh A. J. M., De Groot J. W. B., Jalving M. & Hospers G. A. P. (20200618). Association Between Pembrolizumab-related Adverse Events and Treatment Outcome in Advanced Melanoma: Results From the Dutch Expanded Access Program. : Journal of immunotherapy (Hagerstown, Md. : 1997).

Chicago

Bisschop Cornelis, Wind Thijs T, Blank Christian U, Koornstra Rutger H T, Kapiteijn Ellen, Van den Eertwegh Alfonsus J M, De Groot Jan Willem B, Jalving Mathilde and Hospers Geke A P. 20200618. Association Between Pembrolizumab-related Adverse Events and Treatment Outcome in Advanced Melanoma: Results From the Dutch Expanded Access Program. : Journal of immunotherapy (Hagerstown, Md. : 1997).

Harvard

Bisschop C., Wind T. T., Blank C. U., Koornstra R. H. T., Kapiteijn E., Van den Eertwegh A. J. M., De Groot J. W. B., Jalving M. and Hospers G. A. P. (20200618). Association Between Pembrolizumab-related Adverse Events and Treatment Outcome in Advanced Melanoma: Results From the Dutch Expanded Access Program. : Journal of immunotherapy (Hagerstown, Md. : 1997).

MLA

Bisschop Cornelis, Wind Thijs T, Blank Christian U, Koornstra Rutger H T, Kapiteijn Ellen, Van den Eertwegh Alfonsus J M, De Groot Jan Willem B, Jalving Mathilde and Hospers Geke A P. Association Between Pembrolizumab-related Adverse Events and Treatment Outcome in Advanced Melanoma: Results From the Dutch Expanded Access Program. : Journal of immunotherapy (Hagerstown, Md. : 1997). 20200618.